STAT May 7, 2024
Jason Mast

A young boy died in a trial for Pfizer’s experimental gene therapy for Duchenne muscular dystrophy, the company told patient advocates Tuesday.

The boy was enrolled in Daylight, a trial studying the treatment in boys aged 2 or 3. The boy had received the therapy early last year,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Clinical Trials, Patient / Consumer, Pharma / Biotech, Provider, Trends
Balancing Weight-loss Medication Cost and Care
Marijuana rescheduling moves businesses into ‘uncharted territory’
Orforglipron: the new kid on the GLP-1 block
‘The Time Is Now’: How Employers Can Offer Comprehensive Obesity Care
Weight-Loss Drug Zepbound May Also Treat Obstructive Sleep Apnea. Here’s What To Know About The Disease

Share This Article